![](\"https:\/\/www.veeva.com\/ap\/wp-content\/uploads\/2025\/12\/from-bottlenecks-to-operational-excellence-image-1.jpg\")
\n<\/div>\n<\/p>\nThe Mandate for Operational Excellence<\/strong> One crucial goal, as Ankit highlighted, is to establish a single source of truth for all assets, from global campaigns to local digital components. This foundation allows for rapid content reuse across brands and geographies without ever compromising the integrity of the compliance review process.<\/p>\n Ankit said deploying Veeva PromoMats has made a difference in Himalaya Wellness’ ability to manage its content. By automating the full commercial content lifecycle, from initial concept and collaborative creation through compliant distribution and automated withdrawal, the platform has enabled it to create content that meets regulatory criteria that is published in a timely manner.<\/p>\n “Being a 100-year-old organization, we had very stringent processes and stringent approaches to compliance, and PromoMats allowed us to customize the workflows to an extent that all of our requirements were met,” said Ankit.<\/p>\n PromoMats has improved accountability, reduced confusion and enabled better collaboration between multiple teams, he noted, adding that approval timelines are clearer, so campaigns are planned more efficiently, with the right resources.<\/p>\n Although they only deployed PromoMats fairly recently, Himalaya Wellness have already been reaping clear benefits: assets are now ready between 2 and 3 days, instead of the previous 7 to 10 days.<\/p>\n Modular Content Enables Scale<\/strong> The benefits are clear in pharmaceutical companies that Veeva’s consulting teams have worked with. One reported a 40% growth in content reuse, while others enjoyed 30% reductions in approval time and 20% reductions in the cost of content creation.<\/p>\n Claims management, a crucial part of the content management process, is easily and transparently managed. In PromoMats, every promotional statement must be traceable to its approved, referenced source, whether it is a clinical study, a press release, or an approved label. By establishing a single source of truth for claims, the system ensures that compliance is engineered into the content, not treated as a final, time-consuming review step.<\/p>\n PromoMats also helps to verify claims by auto-linking them to the appropriate claims in a company’s reference library. Whenever a document is uploaded, the claims are auto-linked, saving precious time in manual checks.<\/p>\n Powering Compliance with AI<\/strong> They have also evolved their use of AI, which requires commitment instead of simply installing an AI solution. This is why PromoMats now comes with its first AI feature called Quick Check Agent, which is fine-tuned to enable more powerful content management.<\/p>\n Quick Check Agent provides a set of foundational checks, like spelling, grammar, red flag phrases and box warnings, for any piece of uploaded content. It also looks at other nuances, through a pre-selected set of checks.<\/p>\n Another AI functionality: Content Agent provides context-aware insights into document text and images, answers questions, summarizes content, analyzes visuals, and draws from Quick Check Agent to assist with document review.<\/p>\n In the session I hosted, it was clear that audience members had high expectations of AI, based on the questions they asked. For now, Veeva AI Quick Check Agent will work with fairly standard global regulations, including those from the United States Food and Drug Administration (FDA). Future releases will incorporate more specific local regulations from other jurisdictions as well.<\/p>\n Conclusion: Move Fast, Scale Up<\/strong>
\nIndustry leaders view the content challenge as, fundamentally, a resource and risk problem. Legacy systems, often reliant on manual handoffs and siloed processes, result in excessive rework, costly duplication, and prolonged Medical, Legal, and Regulatory (MLR) review cycles. These inefficiencies delay market entry and undermine global consistency.<\/p>\n
\nTo scale content effectively, a strategic shift is needed in many organizations. They should move from static, monolithic documents to modular content, which enables teams to rapidly assemble personalized, channel-ready assets by pulling from a library that has already been cleared by MLR.<\/p>\n
\nThe next big step in content management is the intelligent application of artificial intelligence (AI). In my experience, almost 90% of top pharmaceutical companies have carried out at least one pilot with AI for content management.<\/p>\n![](\"https:\/\/www.veeva.com\/ap\/wp-content\/uploads\/2025\/12\/from-bottlenecks-to-operational-excellence-image-2.png\")
\n<\/div>\n<\/p>\n![](\"https:\/\/www.veeva.com\/ap\/wp-content\/uploads\/2025\/12\/from-bottlenecks-to-operational-excellence-image-3.png\")
\n<\/div>\n<\/p>\n
\nA content strategy founded on speed, control, and precision is now the goal for many organizations in the medical and pharmaceutical industries. Instead of an operational bottleneck, content that is produced well turns into a core competitive advantage. With the help of AI and other tools, successful content management could deliver the key advantage in a fast-moving industry.<\/p>\n